A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RD / response duration

[Related PubMed/MEDLINE]
Total Number of Papers: 16
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RD  (>> Co-occurring Abbreviation)
Long Form:   response duration
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era. FL
2015 Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study. CBR, ET, HER2, LEA, ORR, OS, PFS, TTF
2014 NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. ARMS, CLL, CR, OS
2012 Phase II Study of Gemcitabine and Docetaxel Combination in Patients with Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. CR, GEMDOC, ORR, PR, SCCHN
2012 The cognitive chronometric architecture of reading aloud: semantic and lexical effects on naming onset and duration. AFM, INST, RT, SND, WF, WT
2011 Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas. BTC, FDR, OS, PFS
2010 Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG). CECOG, ORR, OS, TTP
2010 Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. ASCT, BM, CR, CRu, MCL, MR, MRD, PR
2008 Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. CT, MBC, PET, SUV, TLG
10  2008 Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. CHOP, HLH, OS
11  2006 FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer. MCC, OR, PFS, SD
12  2005 Phase II study of gemcitabine plus 5-fluorouracil biologically modulated by folinic acid plus long-acting formulation of octreotide (LAR) in patients with advanced pancreatic cancer. 5-FU, FA, LAR, RR, SD, TTP
13  2004 Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19. DOX, DPPE, OS, PFS, QOL, RR
14  2003 Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. ADN, AHA, CAD, CLL, IT
15  2002 Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. FL, SFP
16  2000 Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. DOX, FN, MBC, OS, QOL, TTF, TTP, VNB